HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis

[1]  Jian-ning Chen,et al.  Improving pathological early diagnosis and differential biomarker value for hepatocellular carcinoma via RNAscope technology , 2019, Hepatology International.

[2]  Young Nam Kim,et al.  Clinical significance of the pattern-based classification in endocervical adenocarcinoma, usual and variants , 2019, International Journal of Clinical Oncology.

[3]  E. Oliva,et al.  Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC) , 2019, The American journal of surgical pathology.

[4]  J. Berek,et al.  Revised FIGO staging for carcinoma of the cervix uteri , 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  R. Berkowitz,et al.  Liquid biopsy of HPV DNA in cervical cancer. , 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  M. Pike,et al.  Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV. , 2018, Gynecologic oncology.

[7]  M. Pike,et al.  International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix , 2018, The American journal of surgical pathology.

[8]  A. Roma,et al.  Role of Lymphovascular Invasion in Pattern C Invasive Endocervical Adenocarcinoma , 2017, The American journal of surgical pathology.

[9]  Kiyoko Kato,et al.  Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization , 2017, The American journal of surgical pathology.

[10]  Xiao-Jun Ma,et al.  Fully Automated RNAscope In Situ Hybridization Assays for Formalin‐Fixed Paraffin‐Embedded Cells and Tissues , 2016, Journal of cellular biochemistry.

[11]  E. Pirog,et al.  The complex relationship between human papillomavirus and cervical adenocarcinoma , 2016, International journal of cancer.

[12]  Xiao-Jun Ma,et al.  Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice , 2015, Modern Pathology.

[13]  M. Pike,et al.  Gastric-type Endocervical Adenocarcinoma: An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis , 2015, The American journal of surgical pathology.

[14]  Winnie S. Liang,et al.  Simultaneous Characterization of Somatic Events and HPV-18 Integration in a Metastatic Cervical Carcinoma Patient Using DNA and RNA Sequencing , 2014, International Journal of Gynecologic Cancer.

[15]  A. Roma,et al.  Invasive Endocervical Adenocarcinoma: Proposal for a New Pattern-based Classification System With Significant Clinical Implications: A Multi-institutional Study , 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[16]  C. Saenz,et al.  Changing demographics of cervical cancer in the United States (1973-2008). , 2012, Gynecologic oncology.

[17]  R. Shaw,et al.  Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma , 2012, British Journal of Cancer.

[18]  Jason D. Wright,et al.  Prognostic significance of adenocarcinoma histology in women with cervical cancer. , 2012, Gynecologic oncology.

[19]  M. Poetsch,et al.  Alterations in the tumor suppressor gene p16INK4A are associated with aggressive behavior of penile carcinomas , 2011, Virchows Archiv.

[20]  S. Pecorelli.  Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium , 2009 .

[21]  C. Gilks,et al.  Loss of p16 INK4 expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker , 2006, Histopathology.

[22]  D. Jenkins,et al.  p16 Immunoreactivity May Assist in the Distinction Between Endometrial and Endocervical Adenocarcinoma , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[23]  J. Herman,et al.  In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Kenemans.  HPV genotype as a prognostic factor for progression to cervical carcinoma in young women. , 1994, European journal of obstetrics, gynecology, and reproductive biology.

[25]  B. Ronnett.  Endocervical adenocarcinoma: selected diagnostic challenges , 2016, Modern Pathology.

[26]  W. Hop,et al.  Prognostic factors in adenocarcinoma of the uterine cervix. , 2004, Gynecologic oncology.

[27]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[28]  H. Pfister,et al.  Human papillomavirus DNA in genital cancers, metastases, and lymph nodes. , 1995, Intervirology.